Features | n | PAPSS1 | χ2 | P | ||
---|---|---|---|---|---|---|
Positive | Negative | Â | ||||
Mean age |  > 50 | 79 | 49 | 30 | 0.715 | 0.398 |
Ascites |  ≤ 50 | 52 | 36 | 16 |  |  |
Positive | 72 | 43 | 29 | 1.871 | 0.171 | |
Negative | 59 | 37 | 22 | Â | Â | |
FIGO stage | I-II | 68 | 35 | 33 | 11.168 | 0.001 |
III-IV | 63 | 50 | 13 | Â | ||
CA125 (U/ml) |  ≥ 200 | 79 | 48 | 31 | 1.487 | 0.223 |
 < 200 | 52 | 37 | 15 |  | ||
Pathological Subtype | Serous | 92 | 71 | 21 | 20.481 | 0.000 |
Non serous | 39 | 15 | 25 | Â | ||
Tumor grade | G1 | 23 | 11 | 12 | 7.236 | 0.053 |
G2 | 70 | 43 | 27 | Â | ||
G3 | 38 | 22 | 16 | Â | ||
Tumor |  < 10 | 89 | 58 | 31 | 0.010 | 0.921 |
Size |  ≥ 10 | 42 | 27 | 15 |  |  |
Recurrent | Yes | 82 | 59 | 23 | 4.804 | 0.028 |
(3 Years) | No | 49 | 26 | 23 | Â | Â |
Metastasis | Yes | 84 | 57 | 27 | 6.364 | 0.041 |
No | 47 | 23 | 24 | Â | Â | |
CRS | Yes | 84 | 55 | 29 | 0.036 | 0.850 |
No | 47 | 30 | 17 | Â | Â | |
Platinum resistance | Present | 35 | 27 | 8 | 4.395 | 0.040 |
Absent | 96 | 50 | 46 | Â | Â |